We are live on ! Find out more
OCM

Opti Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 0%
This Fund
S&P 500
This Quarter Est. Return
-0.08%
1 Year Est. Return
0%
3 Year Est. Return
-0.01%
5 Year Est. Return
+0.33%
10 Year Est. Return
AUM
$210M
AUM Growth
Cap. Flow
+$985K
Cap. Flow %
0.47%
Top 10 Hldgs %
71.69%
Holding
25
New
3
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$564K
2
WB icon
Weibo
WB
+$381K
3
NVAX icon
Novavax
NVAX
+$38.8K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.76%
2 Communication Services 0.18%
3 Healthcare 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WB icon
1
Weibo
WB
$1.72B
$368K 0.18%
+6,300
New +$381K
SGYP
2
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$98K 0.05%
+860,221
New +$564K
NVAX icon
3
Novavax
NVAX
$1.53B
$39K 0.02%
+1,000
New +$38.8K

Similar funds

Opti Capital Management's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Opti Capital Management, which disclosed 25 positions worth $210M. Its ten largest holdings account for 72% of the portfolio.

Its largest position is Synergy Pharmaceuticals, Inc Common Stock: 860,221 shares worth $98K.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, followed by Communication Services and Healthcare.

  • Opti Capital Management's largest Q4 2018 buy was Synergy Pharmaceuticals, Inc Common Stock: 860,221 shares worth $98K.
  • Opti Capital Management's ten largest holdings make up 72% of its $210M portfolio in Q4 2018.
  • Opti Capital Management disclosed 25 positions in Q4 2018, its first 13F filing on record.

Based on Opti Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.